PatientsVille.com Logo

Dafalgan Side Effects

PatientsVille

Common Dafalgan Side Effects


The most commonly reported Dafalgan side effects (click to view or check a box to report):

Hepatitis (5)
Renal Failure Acute (5)
Blood Alkaline Phosphatase Increased (4)
Fall (4)
Gamma-glutamyltransferase Increased (4)
Vomiting (4)
Renal Failure (4)
Haematoma (4)
Alanine Aminotransferase Increased (3)
Agitation (3)
Aspartate Aminotransferase Increased (3)
Diarrhoea (3)
Cytolytic Hepatitis (3)
Overdose (3)
Hypotension (2)
Hypothyroidism (2)
Hypokalaemia (2)
Sepsis (2)
Pneumonia (2)
Hypocalcaemia (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Dafalgan Side Effects Reported to FDA



Dafalgan Side Effect Report#9777940
Pancreatic Carcinoma Metastatic
This is a report of a 72-year-old female patient (weight: NA) from FR, suffering from the following health symptoms/conditions: NA, who was treated with Dafalgan Tabs 1 Gm (dosage: NA, start time:
Jun 22, 2013), combined with:
  • Metformin Hcl
  • Janumet (Janumet 50mg/1000mg,film-coated Tab.)
  • Repaglinide
  • Loxen Lp (50 Mg, Extended-release Caps.?1df= 1 Caps.)
  • Diffu-k (Caps)
  • Lasilix
  • Celiprolol Hcl
  • Allopurinol
and developed a serious reaction and side effect(s): Pancreatic Carcinoma Metastatic after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dafalgan Tabs 1 Gm treatment in female patients, resulting in Pancreatic Carcinoma Metastatic side effect.
Dafalgan Side Effect Report#9691123
Vomiting, Abdominal Pain, Overdose
This report suggests a potential Dafalgan Oral Vomiting side effect(s) that can have serious consequences. A 26-year-old male patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: toothache and used Dafalgan Oral (dosage: 1 Single Intake) starting
Oct 05, 2013. After starting Dafalgan Oral the patient began experiencing various side effects, including: Vomiting, Abdominal Pain, OverdoseAdditional drugs used concurrently:
  • Efferalgan (1 Single Intake)
  • Baraclude Tabs 1.0 Mg (1df= 1 Tablet.?1 Single Intake)
Although Dafalgan Oral demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Vomiting, may still occur.
Dafalgan Side Effect Report#9420131
Confusional State
This Confusional State problem was reported by a consumer or non-health professional from FR. A 88-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
May 12, 2013 this consumer started treatment with Dafalgan Codeine Tabs (dosage: 1df:1 Tabs? Film Coated Tabs). The following drugs were being taken at the same time:
  • Metformin Hcl
  • Zolpidem
  • Atacand (Scored Tablet)
  • Mono-tildiem
  • Januvia
  • Inexium (Gastro-resistant Tablet)
  • Furadantine
When using Dafalgan Codeine Tabs, the patient experienced the following unwanted symptoms/side effects: Confusional StateThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Confusional State, may become evident only after a product is in use by the general population.
Dafalgan Side Effect Report#9355654
Hepatic Enzyme Increased, Pneumonia
This Hepatic Enzyme Increased side effect was reported by a physician from CH. A 59-year-old female patient (weight:NA) experienced the following symptoms/conditions: pain,psychotic disorder,tachycardia,pneumonia bacterial,hypothyroidism,embolism arterial,thrombosis,constipation.The patient was prescribed Dafalgan (drug dosage: NA), which was initiated on 201303. Concurrently used drugs:
  • Abilify
  • Beloc-zok
  • Co-amoxicillin
  • Euthyrox
  • Clexane
  • Clexane
  • Laxoberon
  • Quetiapine
.After starting to take Dafalgan the consumer reported adverse symptoms, such as: Hepatic Enzyme Increased, PneumoniaThese side effects may potentially be related to Dafalgan. The patient was hospitalized.
Dafalgan Side Effect Report#8401755-1
Haematoma, International Normalised Ratio Increased, Fall, Pain, Atrial Fibrillation
This is a report of a 85-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: pain, who was treated with Dafalgan Codeine (panadeine Co) (coated Tablet) (paracetamol, Codeine) (dosage: 6 Df (6 Df, 1 In 1 D), start time:
Jan 31, 2012), combined with:
  • Nitriderm (lyceryl Trinitrate)
  • Levothyroxine Sodium (1 Df (1 Df, 1 In 1 D))
  • Furosemide
  • Gaviscon
  • Previscan (fluindione) (fluindione) (1.25 Or 1.5 One In Two Days)
  • Crestor (1 Df (1 Df, 1 In 1 D))
  • Bisoprolol Fumarate
  • Repaglinide
and developed a serious reaction and side effect(s): Haematoma, International Normalised Ratio Increased, Fall, Pain, Atrial Fibrillation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dafalgan Codeine (panadeine Co) (coated Tablet) (paracetamol, Codeine) treatment in male patients, resulting in Haematoma side effect. The patient was hospitalized.
Dafalgan Side Effect Report#8229851-2
Fall, Skull Fractured Base, Haemorrhage, International Normalised Ratio Increased
This report suggests a potential Dafalgan Caps 500 Mg Fall side effect(s) that can have serious consequences. A 94-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Dafalgan Caps 500 Mg (dosage: 1 Df: 2 Capsules) starting NS. After starting Dafalgan Caps 500 Mg the patient began experiencing various side effects, including: Fall, Skull Fractured Base, Haemorrhage, International Normalised Ratio IncreasedAdditional drugs used concurrently:
  • Rabeprazole Sodium (Gastro-resistant Tablet)
  • Bisoprolol Fumarate (Film-coated Tablet)
  • Coumadin (1df: 0.5 Df)
The patient was hospitalized. Although Dafalgan Caps 500 Mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Fall, may still occur.
Dafalgan Side Effect Report#7711755-2
Lumbar Spinal Stenosis, Haematoma
This Lumbar Spinal Stenosis problem was reported by a physician from Belgium. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Nov 01, 2006 this consumer started treatment with Dafalgan Codeine (dosage: NA). The following drugs were being taken at the same time:
  • Diclofenac Sodium
  • Lipitor
  • Tramadol Hcl
  • Methotrexate
  • Golimumab
  • Methotrexate
  • Golimumab
  • Xenical
When using Dafalgan Codeine, the patient experienced the following unwanted symptoms/side effects: Lumbar Spinal Stenosis, HaematomaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Lumbar Spinal Stenosis, may become evident only after a product is in use by the general population.
Dafalgan Side Effect Report#7570983-X
Hyperhidrosis, Tachycardia, Pain In Extremity, Loss Of Consciousness, Hypotension, Hyperthermia
This Hyperhidrosis side effect was reported by a health professional from Denmark. A 45-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Dafalgan Codein (panadeine Co) (tablets) (panadeine Co) (drug dosage: NA), which was initiated on
May 11, 2011. Concurrently used drugs:
  • Escitalopram (20 Mg (10 Mg, 2 In 1 D), Oral)
  • Lexomil (bromazepam) (tablets) (bromazepam)
  • Tercian (cyamemazine) (cyamemazine)
  • Tramadol Hydrochloride (300 Mg (150 Mg, 2 In 1 D), Oral)
  • Xylocaine Visqueus (xylocain Viscos /02029501/) (gel) (xylocain Viscos
.After starting to take Dafalgan Codein (panadeine Co) (tablets) (panadeine Co) the consumer reported adverse symptoms, such as: Hyperhidrosis, Tachycardia, Pain In Extremity, Loss Of Consciousness, Hypotension, HyperthermiaThese side effects may potentially be related to Dafalgan Codein (panadeine Co) (tablets) (panadeine Co).
Dafalgan Side Effect Report#7558939-4
Fall, Dermatitis Allergic, Femoral Neck Fracture, Renal Failure Acute, Rash Erythematous
This is a report of a 94-year-old female patient (weight: NA) from Germany, suffering from the following health symptoms/conditions: NA, who was treated with Dafalgan (paracetamol, Codeine Phosphate) (tablets) (paracetamol, Code (dosage: NA, start time:
Dec 23, 2010), combined with:
  • Furosemide
  • Memantine
  • Memantine (10 Mg (10 Mg, 1 In 1 D), Oral; 5 Mg (5 Mg, 1 In 1 D), Oral)
  • Memantine (10 Mg (10 Mg, 1 In 1 D), Oral; 5 Mg (5 Mg, 1 In 1 D), Oral)
  • Cefuroxime (3000 Mg (1500 Mg, 2 In 1 D), Intravenous (not Otherwise Specified))
  • Levothyroxine Sodium (100 Microgram (100 Mcg, 1 In 1 D) Long Term Treatment-)
  • Aspirin Cardio (acetylsalicylic Acid) (tablets) (acetylsalicylic Acid)
  • Torsemide (10 Mg (10 Mg, 1 In 1 D); 25 Mg (25 Mg, 1 In 1 D))
and developed a serious reaction and side effect(s): Fall, Dermatitis Allergic, Femoral Neck Fracture, Renal Failure Acute, Rash Erythematous after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dafalgan (paracetamol, Codeine Phosphate) (tablets) (paracetamol, Code treatment in female patients, resulting in Fall side effect. The patient was hospitalized.
Dafalgan Side Effect Report#7470050-X
Chest Discomfort
This report suggests a potential Dafalgan Chest Discomfort side effect(s) that can have serious consequences. A 48-year-old female patient (weight: NA) from France was diagnosed with the following symptoms/conditions: pain,spondylitis and used Dafalgan (dosage: 1 G, As Needed) starting
Jul 01, 2007. After starting Dafalgan the patient began experiencing various side effects, including: Chest DiscomfortAdditional drugs used concurrently:
  • Sulfasalazine (1000 Mg, 2x/day)
  • Trileptal (150 Mg, 3x/day)
  • Laroxyl (25 Mg (1 Df), 1x/day)
  • Levothyroxine Sodium (25 Ug (1 Df), 1x/day)
Although Dafalgan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Chest Discomfort, may still occur.
Dafalgan Side Effect Report#7459876-6
Chest Discomfort
This Chest Discomfort problem was reported by a pharmacist from France. A 48-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: pain. On
Jul 01, 2007 this consumer started treatment with Dafalgan (dosage: 1 G, As Needed). The following drugs were being taken at the same time:
  • Laroxyl (25 Mg (1 Df), 1x/day)
  • Trileptal (150 Mg, 3x/day)
  • Salazopyrine (1000 Mg, 2x/day)
  • Levothyrox (25 Ug (1 Df), 1x/day)
When using Dafalgan, the patient experienced the following unwanted symptoms/side effects: Chest DiscomfortAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Chest Discomfort, may become evident only after a product is in use by the general population.
Dafalgan Side Effect Report#7458558-4
Haemoglobin Decreased
This Sudden Death side effect was reported by a physician from France. A female patient (weight:NA) experienced the following symptoms/conditions: arthralgia,hypertension.The patient was prescribed Dafalgan (drug dosage: 3 G), which was initiated on
Feb 22, 2011. Concurrently used drugs:
  • Eupressyl (120 Mg)
  • Xyzal (10 Mg)
  • Pradaxa (220 Mg)
  • Lovenox (4000 U)
  • Topalgic (300 Mg)
  • Hydergine (4.5 Mg)
  • Nisisco (160 Mg/25 Mg)
  • Tardyferon
.After starting to take Dafalgan the consumer reported adverse symptoms, such as: Haemoglobin DecreasedThese side effects may potentially be related to Dafalgan.
Dafalgan Side Effect Report#7446182-9
Obsessive-compulsive Disorder, Depressed Mood, Anxiety
This is a report of a male patient (weight: NA) from Switzerland, suffering from the following health symptoms/conditions: headache,multiple sclerosis, who was treated with Dafalgan (dosage: NA, start time:
Apr 01, 2009), combined with:
  • Rebif
and developed a serious reaction and side effect(s): Obsessive-compulsive Disorder, Depressed Mood, Anxiety after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dafalgan treatment in male patients, resulting in Obsessive-compulsive Disorder side effect.
Dafalgan Side Effect Report#7438133-8
Liver Injury, Rash Maculo-papular
This report suggests a potential Dafalgan Liver Injury side effect(s) that can have serious consequences. A 81-year-old female patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Dafalgan (dosage: Unk) starting
Jan 21, 2011. After starting Dafalgan the patient began experiencing various side effects, including: Liver Injury, Rash Maculo-papularAdditional drugs used concurrently:
  • Celebrex (Unk)
  • Lyrica (Unk)
  • Amlodipine Besylate (Unk)
  • Amlodipine Besylate (Unk)
  • Acupan (Unk)
  • Pradaxa (Unk)
  • Kardegic (Unk)
  • Acupan (Unk)
The patient was hospitalized. Although Dafalgan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Liver Injury, may still occur.
Dafalgan Side Effect Report#7435949-9
This Sudden Cardiac Death problem was reported by a physician from Switzerland. A 61-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Feb 05, 2011 this consumer started treatment with Dafalgan (dosage: NA). The following drugs were being taken at the same time:
  • Prazine
  • Temesta
  • Seroquel (400 Mg Twice A Day In The Evening)
  • Seroquel
  • Depakene (1000-0-500 Mg Daily)
  • Buscopan
  • Seroquel
  • Seroquel
When using Dafalgan, the patient experienced the following unwanted symptoms/side effects:Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Sudden Cardiac Death, may become evident only after a product is in use by the general population.
Dafalgan Side Effect Report#7435194-7
Gastroenteritis, Hypokalaemia, Blood Sodium Increased, Electrolyte Imbalance, Renal Failure Acute, Acidosis Hyperchloraemic
This Gastroenteritis side effect was reported by a physician from Switzerland. A 62-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Dafalgan (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Zestril
  • Calcium D3-mepha (1200mg/800 Iu Daily)
  • Spiralgin
  • Condrosulf
  • Neurontin
  • Seroquel Xr
  • Citalopram
.After starting to take Dafalgan the consumer reported adverse symptoms, such as: Gastroenteritis, Hypokalaemia, Blood Sodium Increased, Electrolyte Imbalance, Renal Failure Acute, Acidosis HyperchloraemicThese side effects may potentially be related to Dafalgan. The patient was hospitalized.
Dafalgan Side Effect Report#7434625-6
Systemic Sclerosis, Hepatic Steatosis, Gastritis Erosive
This is a report of a 59-year-old female patient (weight: NA) from Switzerland, suffering from the following health symptoms/conditions: NA, who was treated with Dafalgan /00020001/ (dosage: Unk, start time:
Apr 30, 2010), combined with:
  • Etanercept
  • Pantozol /01263202/ (Unk)
  • Fraxiparin /00889603/ (Unk)
  • Fraxiparin /00889603/ (Unk)
  • Dafalgan /00020001/ (Unk)
  • Etanercept (50 Mg, Qwk)
  • Methotrexate Sodium (10-25 Mg Once Weekly)
and developed a serious reaction and side effect(s): Systemic Sclerosis, Hepatic Steatosis, Gastritis Erosive after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dafalgan /00020001/ treatment in female patients, resulting in Systemic Sclerosis side effect. The patient was hospitalized.
Dafalgan Side Effect Report#7400584-5
Decreased Appetite, Rash Pruritic, Escherichia Urinary Tract Infection, Weight Decreased, Shift To The Left, Constipation, Abdominal Pain Upper, Hypokalaemia, Cytolytic Hepatitis
This report suggests a potential Dafalgan Decreased Appetite side effect(s) that can have serious consequences. A 86-year-old female patient (weight: NA) from Switzerland was diagnosed with the following symptoms/conditions: NA and used Dafalgan (dosage: 1 G, 4x/day) starting
Jan 07, 2011. After starting Dafalgan the patient began experiencing various side effects, including: Decreased Appetite, Rash Pruritic, Escherichia Urinary Tract Infection, Weight Decreased, Shift To The Left, Constipation, Abdominal Pain Upper, Hypokalaemia, Cytolytic HepatitisAdditional drugs used concurrently:
  • Fentanyl (1 Df, 2x/week Every 3 Days)
  • Tolterodine Tartrate (4 Mg, 1x/day)
  • Januvia (100 Mg, 1x/day)
  • Motilium (10 Mg, 3x/day)
  • Zolpidem (5 Mg, 1x/day)
  • Remeron (30 Mg, 1x/day)
The patient was hospitalized. Although Dafalgan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Decreased Appetite, may still occur.
Dafalgan Side Effect Report#7391046-2
Hypoglycaemia
This Hypoglycaemia problem was reported by a health professional from Switzerland. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Dafalgan (dosage: NA). The following drugs were being taken at the same time:
  • Tramadol Hydrochloride
  • Irfen
  • Physiotens
  • Singulair
  • Nasonex
  • Duspatalin
  • Seretide
  • Coaprovel
When using Dafalgan, the patient experienced the following unwanted symptoms/side effects: HypoglycaemiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hypoglycaemia, may become evident only after a product is in use by the general population.
Dafalgan Side Effect Report#7383294-2
Abortion Missed
This Abortion Missed side effect was reported by a physician from Switzerland. A 36-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Dafalgan (drug dosage: NA), which was initiated on
Dec 24, 2005. Concurrently used drugs:
  • Relpax (40 Mg, Single)
  • Pantozol (40 Mg, 1x/day)
.After starting to take Dafalgan the consumer reported adverse symptoms, such as: Abortion MissedThese side effects may potentially be related to Dafalgan.
Dafalgan Side Effect Report#7375907-6
Dyspnoea, Dysphonia, Face Oedema, Dysphagia, Hypersensitivity, Angioedema, Lip Oedema
This is a report of a 27-year-old female patient (weight: NA) from France, suffering from the following health symptoms/conditions: tonsillitis, who was treated with Dafalgan (dosage: 2tab Single Dose, start time:
Sep 20, 2010), combined with:
  • Derinox
  • Domperidone (1tab Single Dose)
  • Augmentin (1g Single Dose)
and developed a serious reaction and side effect(s): Dyspnoea, Dysphonia, Face Oedema, Dysphagia, Hypersensitivity, Angioedema, Lip Oedema after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dafalgan treatment in female patients, resulting in Dyspnoea side effect. The patient was hospitalized.
Dafalgan Side Effect Report#7356608-7
Bile Duct Stone, Gastritis, Hepatitis Acute, Abdominal Pain Upper
This report suggests a potential Dafalgan Bile Duct Stone side effect(s) that can have serious consequences. A 51-year-old female patient (weight: NA) from Switzerland was diagnosed with the following symptoms/conditions: back pain and used Dafalgan (dosage: 1 G, Qid) starting
Dec 11, 2010. After starting Dafalgan the patient began experiencing various side effects, including: Bile Duct Stone, Gastritis, Hepatitis Acute, Abdominal Pain UpperAdditional drugs used concurrently:
  • Sirdalud (2 Mg, Bid)
  • Bi-profenid (150 Mg, Qd)
  • Nexium (40 Mg, Qd)
  • Prednisone (Unk)
  • Ecofenac (75 Mg, Bid)
The patient was hospitalized. Although Dafalgan demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Bile Duct Stone, may still occur.
Dafalgan Side Effect Report#7348439-9
Multi-organ Failure, Cardiac Arrest, Coma, Neoplasm Malignant, Renal Impairment, Hepatic Function Abnormal, Malaise
This Multi-organ Failure problem was reported by a physician from Belgium. A 69-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: bone pain,prostate cancer. On
Dec 27, 2010 this consumer started treatment with Dafalgan (dosage: 1 G, Tid). The following drugs were being taken at the same time:
  • Androcur (50 Mg, Tid)
  • Zometa (5 Mg, Unk)
When using Dafalgan, the patient experienced the following unwanted symptoms/side effects: Multi-organ Failure, Cardiac Arrest, Coma, Neoplasm Malignant, Renal Impairment, Hepatic Function Abnormal, MalaiseThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Multi-organ Failure, may become evident only after a product is in use by the general population.
Dafalgan Side Effect Report#7342696-0
Metabolic Acidosis, Hyperkalaemia, Ventricular Tachycardia, Renal Failure Acute
This Metabolic Acidosis side effect was reported by a health professional from France. A 83-year-old female patient (weight:NA) experienced the following symptoms/conditions: pain.The patient was prescribed Dafalgan (drug dosage: Unk 6x/days), which was initiated on
Jan 24, 2011. Concurrently used drugs:
  • Celebrex (200 Mg, 1x/day)
  • Lovenox (4000 Iu, 1x/day)
  • Mopral (20 Mg, 1x/day)
.After starting to take Dafalgan the consumer reported adverse symptoms, such as: Metabolic Acidosis, Hyperkalaemia, Ventricular Tachycardia, Renal Failure AcuteThese side effects may potentially be related to Dafalgan.
Dafalgan Side Effect Report#7339240-0
Mucosal Induration
This is a report of a 63-year-old female patient (weight: NA) from Switzerland, suffering from the following health symptoms/conditions: arthralgia,hypopituitarism, who was treated with Dafalgan (dosage: NA, start time: NS), combined with:
  • Eltroxin
  • Hydrocortisone
  • Golimumab
  • Methotrexate
  • Tambocor
  • Golimumab
and developed a serious reaction and side effect(s): Mucosal Induration after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Dafalgan treatment in female patients, resulting in Mucosal Induration side effect. The patient was hospitalized.


1 of 2 


The appearance of Dafalgan on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Dafalgan reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Dafalgan Side Effects

    Did You Have a Dafalgan Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Dafalgan for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Dafalgan Safety Alerts, Active Ingredients, Usage Information

    More About Dafalgan

    Side Effects reported to FDA: 49

    Dafalgan safety alerts: No

    Reported deaths: 5

    Reported hospitalizations: 20

    Latest Dafalgan clinical trials